Germ Cell Tumors

15 registered clinical trials studyying Germ Cell Tumors — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphod NCT05092451	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Withdrawn	Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patie NCT04648826	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors. NCT04283773	Assiut University	—
Withdrawn	Nivolumab in Platinum Recurrent or Refractory Metastatic Germ Cell Tumors NCT03726281	Hospital Beatriz Ângelo	Phase 2
Terminated	A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumor NCT02536183	AeRang Kim	Phase 1
Terminated	Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors NCT02689219	Nabil Adra	Phase 2
Completed	Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors NCT02390843	Emory University	Phase 1
Completed	Molecular-Guided Therapy for Childhood Cancer NCT02162732	Giselle Sholler	N/A
Active Not Recruiting	Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With P NCT01873326	Memorial Sloan Kettering Cancer Center	Phase 2
Completed	Pazopanib in Advanced and Cisplatin-resistant Germ Cell Tumors NCT01743482	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano	Phase 2
Completed	Auto Transplant for High Risk or Relapsed Solid or CNS Tumors NCT01505569	Masonic Cancer Center, University of Minnesota	N/A
Completed	Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis NCT00864318	Institut Claudius Regaud	Phase 2
Completed	Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors NCT00572572	Hoosier Cancer Research Network	Phase 3
Completed	Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy NCT00187109	St. Jude Children's Research Hospital	Phase 1 / Phase 2
Completed	Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors NCT02161692	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano	Phase 2